In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected ...

Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease Indications; Inno ...

AUSTIN, TX, USA and HAMILTON, Canada and SAN DIEGO, CA, USA I7, 2025 I Triumvira Immunologics, a clinical-stage company ...

India's role in affordable cell and gene therapies, including CAR-T, and the need for a mission mode approach.

The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. . Shareholders who purchased shares ...

The global market for oncology drugs was valued at US$231.56 billion last year and is projected to soar to US$532.91 billion by 2031, according to Coherent (NYSE: COHR) Market Insights.

NDAQ:CRBU) Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CRBU ...